Trial Profile
Flibanserin and Women With Hypoactive Sexual Desire Disorder: A Double-Blind, Randomized, Electrical Neuroimaging Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jan 2023
Price :
$35
*
At a glance
- Drugs Flibanserin (Primary)
- Indications Decreased libido; Female sexual dysfunction
- Focus Therapeutic Use
- 15 Jan 2021 Planned End Date changed from 1 Jun 2020 to 21 Dec 2021.
- 15 Jan 2021 Planned primary completion date changed from 1 Jun 2020 to 21 Dec 2021.
- 15 Jan 2021 Status changed from recruiting to active, no longer recruiting.